AWhat changed
Reported a new beta-adrenergic antagonist and early pharmacological/clinical effects.
Scientific scope
The record is the exact five-author 1964 Lancet report. It does not establish every later indication, long-term benefit or safety profile of beta blockers, and it does not absorb preceding pronethalol work or subsequent randomized trials.
Evidence
The linked sources identify this contribution and its scope. WRS has not independently reconstructed the scientific claims. The record is the exact five-author 1964 Lancet report. It does not establish every later indication, long-term benefit or safety profile of beta blockers, and it does not absorb preceding pronethalol work or subsequent randomized trials.
Contributors
- J. W. Black · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
- A. F. Crowther · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
- R. G. Shanks · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
- L. H. Smith · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
- A. C. Dornhorst · SCIENCE: Named source author of the scoped work; individual effort shares are not measured.
Provisional WRS assessment, edition 2026-10-16.1. Independent expert calibration is pending. This grade does not certify correctness or assign ownership.
Full scientific record · Browse contribution grades · Request a correction